Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Jean-Jacques Lafitte"'
Autor:
Michelle Coureau, Georgiana Bentea, Anne-Pascale Meert, Lucien Ruelle, Bogdan Grigoriu, Julie Gorham, Jean-Paul Sculier, Valérie Durieux, Jean-Jacques Lafitte, Spyridon Sideris, Thierry Berghmans, Stéphane Holbrechts, Claudine Sculier
Publikováno v:
Lung Cancer. 111:164-175
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic
Autor:
Muhammad Siddique, Connie Yip, David Landau, Jacques Remy, Vicky Goh, Paul Bassett, Frederic Wallyn, Arnaud Scherpereel, Gary Cook, Martine Remy-Jardin, Nunzia Tacelli, Alexis B. Cortot, Jean-Jacques Lafitte
Publikováno v:
Journal of Thoracic Imaging. 30:300-307
Purpose We aimed to assess computed tomography (CT) intratumoral heterogeneity changes, and compared the prognostic ability of the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1, an alternate response method (Crabb), and CT heterogeneity i
Autor:
Thierry Berghmans, Arnaud Scherpereel, Anne-Pascale Meert, Vicente Giner, Jacques Lecomte, Jean-Jacques Lafitte, Nathalie Leclercq, Marianne Paesmans, Jean-Paul Sculier, for the European Lung Cancer Working Party (ELCWP)
Publikováno v:
Frontiers in Oncology
Frontiers in oncology, 7
Frontiers in Oncology, Vol 7 (2017)
Frontiers in oncology, 7
Frontiers in Oncology, Vol 7 (2017)
Introduction: In a literature meta-analysis, we showed survival benefits for regimens including cisplatin [hazard ratio (HR) 0.61; 95% confidence interval (CI), 0.57-0.66] and for those including etoposide (HR 0.65; 0.61-0.69). That benefit was mainl
Autor:
Bogdan Grigoriu, Stéphane Holbrechts, Lucien Ruelle, Anne-Pascale Meert, Georgiana Bentea, Spyridon Sideris, Mohamed El Koulali, Thierry Berghmans, Claudine Sculier, Valérie Durieux, Jean-Paul Sculier, Jean-Jacques Lafitte
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 111
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic
Autor:
Arnaud Scherpereel, Thierry Berghmans, Jean-Paul Sculier, Marianne Paesmans, Jean-Jacques Lafitte, Anne-Pascale Meert, Nathalie Leclercq, Jacques Lecomte, V. Giner
Publikováno v:
11.1 Lung Cancer.
In a meta-analysis of the literature (Lung Cancer 30: 23-36; 2000), we showed survival benefits for regimens including cisplatin (Hazard ratio HR 0.61; 95 % CI, 0.57–0.66) and for those including etoposide (HR 0.65; 0.61–0.69).That benefit was ma
Autor:
Arnaud Scherpereel, Thierry Berghmans, Alexis B. Cortot, Céline Mascaux, Jean-Paul Sculier, Ingrid CsToth, Lieveke Ameye, Marianne Paesmans, Luc Willems, Anne-Pascale Meert, L Toussaint, Nathalie Leclercq, Tiffany Dernies, Jean-Jacques Lafitte
Publikováno v:
Lung Cancer. 82:340-345
Clinical variables, like stage and performance status (PS), have predictive and prognostic values in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy, not allowing adequate individual prediction. MicroRNA (miRNA) are non
Autor:
Jean-Jacques Lafitte, Gregory Petyt, Stefanie Habib, Julie Delourme, Alexis B. Cortot, Nunzia Tacelli, Arnaud Scherpereel, Xavier Dhalluin
Publikováno v:
Lung Cancer. 80:197-202
Background Combination of bevacizumab and weekly paclitaxel showed synergitic effects, anti-tumor efficacy and a good toxicity profile for patients with breast cancer but has never been evaluated in non small cell lung cancer (NSCLC). We retrospectiv
Autor:
Arnaud Scherpereel, Alexis B. Cortot, J. Taverne, Jean-Jacques Lafitte, Marie-Christine Copin, J. Delourme, Xavier Dhalluin
Publikováno v:
Revue de Pneumologie Clinique. 69:36-40
We report the case of a 55-year-old woman with pulmonary adenocarcinoma and bone metastases who was diagnosed with paraneoplastic secretion of the beta subunit of human chorionic gonadotropin (beta-HCG) while being screened for inclusion in a clinica
Autor:
Anne-Pascale Meert, Olivier Van Cutsem, Vicente Giner, Martine Roelandts, Nathalie Leclercq, Yves Bonduelle, Arnaud Scherpereel, Thierry Berghmans, Benoit Colinet, Jean-Paul Sculier, Jean-Jacques Lafitte, Paul Van Houtte, Marianne Paesmans
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 117
Objectives To assess if induction radiochemotherapy followed by consolidation chemotherapy (arm A) will improve survival in comparison with the same chemotherapy given as induction followed by consolidation concurrent radiochemotherapy (arm B) in pat
Autor:
Jean-Paul Sculier, Marianne Paesmans, Nathalie Leclercq, Vicente Giner, O Van Cutsem, Arnaud Scherpereel, Thierry Berghmans, Jean-Sébastien Lecomte, P. Van Houtte, Anna Efremidis, Jean-Jacques Lafitte, Anne-Pascale Meert
Publikováno v:
European Respiratory Journal. 38:657-663
It is commonly considered that idiopathic pulmonary fibrosis (IPF) predisposes to the occurrence of lung cancer (LC). The frequency of IPF and LC coexistence is assessed at 4,8% to 48,2% depending on the country of origin and type of the report. Base